Policy | March 02, 2024
Cabinet approves post of director for National Institute for One Health
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
The board gave in-principle approval for expansion of company's footprint in Lucknow
he lower sales in the current quarter are mainly on account of a one?time impact on the company’s India business
The CDCCs are strategically positioned in regions identified as high-impact areas
The US FDA's clearance of the trial marks the first global registrational Phase III trial for olverembatinib in patients with CP-CML to be conducted.
_256_384.png){kind=logo}
4 FDA clearances & 61 EU MDR CE tags achieved for AI in 18 months
Global TB incidence saw a reduction of 8.7% while in India we were able to demonstrate a reduction of 16%, almost double the pace
The initiative, “Change the Odds: Uniting to Improve Cancer Outcomes” aims to enhance awareness of and access to cancer screening, clinical trials and support
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
Subscribe To Our Newsletter & Stay Updated
